The causal association of GDF-15 with some cardiovascular diseases (e.g., coronary artery disease and myocardial infarction), whereas no relationship with others (e.g., ischemic stroke and heart failure), has recently raised the promising role of GDF-15 as a potential biomarker or therapeutic target [51]. The gene discussed is GDF15; the disease is myocardial infarction.